We focus on
SERB (Société d’Étude et de Recherche Biologique) is a specialty pharmaceuticals group created in the 50’s.
Our mission has always been to bring life saving drugs that meet high unmet medical needs.
The Emergency care franchise has been developped with selected antidotes portfolio answering essential medical needs.
In the last decade, the group has extended its portfolio with acquisitions addressing niche indications, enlarging the Rare Diseases franchise. In addition, SERB has continously expanding its international presence to ensure a global availability of their medicines.
SERB has accelerated its strategic transformation with a strong acquisition/licencing track record initiated the past 10 years.